Does OCRELIZUMAB Cause Hyperhidrosis? 317 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 317 reports of Hyperhidrosis have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.6% of all adverse event reports for OCRELIZUMAB.
317
Reports of Hyperhidrosis with OCRELIZUMAB
0.6%
of all OCRELIZUMAB reports
3
Deaths
89
Hospitalizations
How Dangerous Is Hyperhidrosis From OCRELIZUMAB?
Of the 317 reports, 3 (0.9%) resulted in death, 89 (28.1%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 317 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which OCRELIZUMAB Alternatives Have Lower Hyperhidrosis Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE